Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients
Carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) is one of the most common causes of nosocomial infections in critically ill patients. Colistin methanesulfonate (CMS), an inactive prodrug, has been considered as a last-resort treatment for CRAB infection in critically ill patie...
Saved in:
Main Authors: | Wasan Katip (Author), Suriyon Uitrakul (Author), Peninnah Oberdorfer (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2020) -
Effectiveness and Nephrotoxicity of Loading Dose Colistin-Meropenem versus Loading Dose Colistin-Imipenem in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
by: Wasan Katip, et al.
Published: (2022) -
Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant <i>A.</i><i>baumannii</i> in Cancer Patient
by: Wasan Katip, et al.
Published: (2021) -
Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant <i>Acinetobacter baumannii</i>: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2021) -
High-Loading-Dose Colistin with Nebulized Administration for Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia in Critically Ill Patients: A Retrospective Cohort Study
by: Wasan Katip, et al.
Published: (2024)